Patents by Inventor Jahnabi Arika

Jahnabi Arika has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Non-fucosylated protein and methods thereof
    Patent number: 10077434
    Abstract: The present disclosure relates to developing cell lines where specific biological pathways are modified, particularly by modifications in the enzymes of the cell. The present disclosure develops protein expression systems wherein specific modification of glycan chain of the protein is achieved, which produces non-fucosylated proteins, including non-fucosylated antibodies. The non-fucosylated proteins are used in developing therapeutic monoclonal antibodies and biomarkers, and in diagnosis and prognosis of various diseases. The present disclosure employs the Transcription Activator like Effector Nuclease (TALEN) technology for inactivating fucosylation in a cell.
    Type: Grant
    Filed: July 30, 2015
    Date of Patent: September 18, 2018
    Assignee: Zumutor Biologics Inc.
    Inventors: Sohang Chatterjee, Kavitha Iyer Rodrigues, Maloy Ghosh, Sunit Maity, Rajeshwari Pendse, Divya Unnikrishnan, Yogendra Manjunath B. M., Jahnabi Arika, Sathyabalan M., Pavithra M., Bhargav Prasad, Veeresha K., Prabhat Kumar Pathak, Sanghamitra Bhattacharjee, Pravin Kumar D., Vivek Halan, Sankaranarayanan Srinivasan, Anuradha Hora, Bairavabalakumar N., Karthika Nair, Aswini Thanigaivel, Amol Maliwalave, Bharath R. Shenoy, Anisha Kurup
  • NON-FUCOSYLATED PROTEIN AND METHODS THEREOF
    Publication number: 20170306305
    Abstract: The present disclosure relates to developing cell lines where specific biological pathways are modified, particularly by modifications in the enzymes of the cell. The present disclosure develops protein expression systems wherein specific modification of glycan chain of the protein is achieved, which produces non-fucosylated proteins, including non-fucosylated antibodies. The non-fucosylated proteins are used in developing therapeutic monoclonal antibodies and biomarkers, and in diagnosis and prognosis of various diseases. The present disclosure employs the Transcription Activator like Effector Nuclease (TALEN) technology for inactivating fucosylation in a cell.
    Type: Application
    Filed: July 30, 2015
    Publication date: October 26, 2017
    Applicant: Zumator Biologics, Inc.
    Inventors: Sohang Chatterjee, Kavitha Iyer Rodrigues, Maloy Ghosh, Sunit Maity, Rajeshwari Pendse, Divya Unnikrishnan, Yogendra Manjunath B. M., Jahnabi Arika, Sathyabalan M., Pavithra M., Bhargav Prasad, Veeresha K., Prabhat Kumar Pathak, Sanghamitra Bhattacharjee, Pravin Kumar D., Vivek Halan, Sankaranarayanan Srinivasan, Anuradha Hora, Bairavabalakumar N., Karthika Nair, Aswini Thanigaivel, Amol Maliwalave, Bharath R. Shenoy, Anisha Kurup